Comparison of objective response rate and long-term overall survival in patients with treated immune checkpoint inhibitors in metastatic urothelial carcinoma.

Simple item page
dc.contributor.authorid0000-0002-1273-1674
dc.contributor.coauthorTural, Deniz
dc.contributor.coauthorArslan, Cagatay
dc.contributor.coauthorOlmez, Omer Fatih
dc.contributor.coauthorAkar, Emre
dc.contributor.coauthorErman, Mustafa
dc.contributor.coauthorUrun, Yuksel
dc.contributor.coauthorErdem, Dilek
dc.contributor.coauthorKilickap, Saadettin
dc.contributor.departmentN/A
dc.contributor.kuauthorSelçukbiricik, Fatih
dc.contributor.kuprofileFaculty Member
dc.contributor.schoolcollegeinstituteSchool of Medicine
dc.contributor.yokid202015
dc.date.accessioned2025-01-19T10:34:25Z
dc.date.issued2023
dc.description.indexedbyWoS
dc.description.issue6
dc.description.publisherscopeInternational
dc.description.volume41
dc.identifier.eissn1527-7755
dc.identifier.issn0732-183X
dc.identifier.quartileN/A
dc.identifier.urihttps://hdl.handle.net/20.500.14288/26768
dc.identifier.wos1098050200510
dc.languageen
dc.publisherLippincott Williams and Wilkins
dc.sourceJournal of Clinical Oncology
dc.subjectOncology
dc.titleComparison of objective response rate and long-term overall survival in patients with treated immune checkpoint inhibitors in metastatic urothelial carcinoma.
dc.typeMeeting abstract

Files

Collections

Publications without Fulltext